Sirolomus Adjuvant Treatment of Focal Refractory Epilepsy (SATFRE)

Clinical trial NCT06719791 · RECRUITING

Trial details

NCT number: NCT06719791
Sponsor: Xuanwu Hospital, Beijing
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Epilepsy, Drug Resistant

Start date: 2024-12-23
Primary completion: 2027-12-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.